Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc.verified

ELTP

Price:

$0.51633

Market Cap:

$551.76M

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsul...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-02-24

Stock Exchange

OTC

Ticker

ELTP

The Current Ratio as of December 2025 (TTM) for Elite Pharmaceuticals, Inc. (ELTP) is 8.04

According to Elite Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.04. This represents a change of 37.28% compared to the average of 5.85 of the last 4 quarters.

Elite Pharmaceuticals, Inc. (ELTP) Historical Current Ratio (quarterly & annually)

How has ELTP Current Ratio performed in the past?

The mean historical Current Ratio of Elite Pharmaceuticals, Inc. over the last ten years is 2.98. The current 8.04 Current Ratio has changed 26.83% with respect to the historical average. Over the past ten years (40 quarters), ELTP's Current Ratio was at its highest in in the September 2025 quarter at 8.04. The Current Ratio was at its lowest in in the June 2019 quarter at 1.12.

Quarterly (TTM)
Annual

Average

2.98

Median

2.78

Minimum

1.19

Maximum

5.50

Elite Pharmaceuticals, Inc. (ELTP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Elite Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 76.81%

Maximum Annual Current Ratio = 5.50

Minimum Annual Increase = -52.13%

Minimum Annual Current Ratio = 1.19

Quarterly (TTM)
Annual
YearCurrent RatioChange
20254.8859.03%
20243.0711.67%
20232.75-2.54%
20222.8234.30%
20212.1076.81%
20201.19-7.48%
20191.28-52.13%
20182.68-51.33%
20175.5053.30%
20163.5947.63%

Elite Pharmaceuticals, Inc. (ELTP) Average Current Ratio

How has ELTP Current Ratio performed in the past?

The current Current Ratio of Elite Pharmaceuticals, Inc. (ELTP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

3.56

5-year avg

3.12

10-year avg

2.98

Elite Pharmaceuticals, Inc. (ELTP) Current Ratio vs. Peers

How is ELTP’s Current Ratio compared to its peers?

Elite Pharmaceuticals, Inc.’s Current Ratio is greater than YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1.77), greater than AB Science S.A. (0.71), greater than Torii Pharmaceutical Co., Ltd. (5.18), greater than Swedencare AB (publ) (2.83), greater than Glass House Brands Inc. (1.99), greater than ManifestSeven Holdings Corporation (0.13), greater than Boiron S.A. (2.39), greater than Allergy Therapeutics plc (1.60), greater than Avisa Diagnostics Inc. (0.23), greater than Basilea Pharmaceutica AG (6.32),

Build a custom stock screener for Elite Pharmaceuticals, Inc. (ELTP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elite Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Elite Pharmaceuticals, Inc. (ELTP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Elite Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Elite Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Elite Pharmaceuticals, Inc. (ELTP)?

What is the highest Current Ratio for Elite Pharmaceuticals, Inc. (ELTP)?

What is the 3-year average Current Ratio for Elite Pharmaceuticals, Inc. (ELTP)?

What is the 5-year average Current Ratio for Elite Pharmaceuticals, Inc. (ELTP)?

How does the current Current Ratio for Elite Pharmaceuticals, Inc. (ELTP) compare to its historical average?